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ABSTRACT 
Breast cancer is a commonly diagnosed neoplastic ailment in females particularly near 
menopause. This ailment signifies a substantial health problem as it has influenced a large 
number of women. Several risk factors are associated with breast cancer that cannot be altered, 
but certain can be modified. The existence of risk factors of breast carcinoma does not mean that 
cancer is unavoidable; numerous females having risk factors not ever developed the disease. The 
risk factors aid in identifying the females who may get help at maximum from screening or other 
precautionary measures. It is noteworthy that breast carcinoma can also ensue in females with no 
recognizable risk factors. The augmented occurrence of breast cancer worldwide revealed by 
several epidemiological investigations indicates the need of aiming multidirectional 
investigations so as to ascertain risk factors linked with the incidence of this disease.  
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INTRODUCTION 
Breast carcinoma incidence has been amplified than before universally
1
. Its existence has been 
rising in Asia and it is also recognized as the most widespread malignancy in Asian women
2
. 
Breast carcinoma in Pakistan is on top in Asia after Israel and it is also 2.5 times greater than that 
in various neighboring states
3
.In Pakistan, this cancer is among the topmost 20 reasons of 
deceases
4
. Breast carcinoma risk factors have been investigated and acknowledged in numerous 
researches
5,6
. It is probable that females surviving to 85 years of age would have a 1 in 9 lifetime 
chance of attaining this cancer but the amount of risk is inconsistent through the populace since 
some persons would not ever develop breast carcinoma while others would be at augmented 
risk
7
. Breast cancer is often diagnosed in females around menopause thereby reducing their 
capability to function normally in daily life. Researches done since over the years revealed that 
20-30% of new cases of breast cancer might be related to the manifestation of different risk 
factors that actively start or modify the course of breast cells neoplastic transformation e.g. age 
above 40 years, family history in first-degree members, early menarche and late childbirth (after 
the age of 35 years), etc
8
.Even though various factors augmenting the risk of breast cancer 
incidence have been recognized, yet no risk factor is found in 75-80% of females
8
.  
RISK FACTORS 
If the risk factors of breast carcinoma are present in an individual, it does not ascertain that 
cancer is unavoidable; numerous females with risk factors not ever attained breast cancer. 
However, the risk factors aid in identifying the females who can get help from screenings or 
further preventive processes. It is should also be remembered that breast carcinoma can also 
develop in females having no identifiable risk elements
9
. 
Types of Risk Factors: 
Various risk factors linked with breast cancer cannot be changed, but certain can be modified. 
1. Non-modifiable risk factors are intrinsic; all of them institute independent factors and do not 
go through simple alteration in a person's life
10
.The ACS
11
 includes non-modifiable risk factors 
for breast cancer e.g. gender, progressing age, genetic features, race, ethnicity, family history, 
dense breast tissue, certain benign breast conditions, previous chest radiations tobacco smoke, 
and exposure to diethylstilbestrol
4
. 
 2. Modifiable risk factors are extrinsic factors; they may modify neoplastic course to a certain 
level. If modifiable factors are identified then they may be helpful in developing prevention 
schemes thereby reducing breast cancer occurrence
10
.Lifestyle-related risk factors take account 
of the birth control, number of children given birth to, breastfeeding, hormone therapy, 
overweight or obesity, alcohol use and physical activity. 
3. Controversial risk factors have uncertain, debatable or unconfirmed effect on the risk of 
attaining breast carcinoma i.e. diet and vitamin intake, induced abortions, chemicals in the 
environment, etc.
11,4 
Different risk factors of breast cancer are discussed as follows: 
 
STANDARD RISK FACTORS: 
1. Gender: 
 Breast cancer is very common in females and is 100 times as compared to the males
9
.  
2. Age: 
It is the primary, strongest risk factor and is proportional to risk
4
i.e its relationship with breast 
carcinoma is stated to be slighter in youngsters but then it surges as the age is more than 40 
years
12
.Also, if the females of < 65 years of age are related with females having 65 years of age 
or more, the relative risk of breast carcinomalinked with increasing age is reported to be 5.8
7
. 
3. Education and Socio-Economic Status: 
These are considered as important aspects concerning the occurrence of breast cancer. Due to 
poorer education level and low SES, there are patients’ deferments to seek medical support from 
the healthcare centers
13
. Those females who are educated and have a relatively higher SES, get 
more into contact and avail healthcare services and hence are recognized to be linked with breast 
cancer
14,15
. This leads to reduction in mortality rates of breast cancer due to timely identification 
of the ailment and prompt commencement of its management
16
. It has also been reported that the 
females of higher socio-economic status with early menarche, late menopause and those who 
conceived in 30 years of age are at a greater risk of developing breast cancer
17
; also, women with 
more than 40 years of age with higher social class have greater risk
18
.  As revealed in various 
investigations, this association is linked with the point that females in developed nations have on 
average lesser children, and also partial and infrequent period of breastfeeding
19
.Those women 
who have increasing age with middle class family background, greater body mass index and an 
increased ratio of incomplete pregnancies are at considerably greater risk of developing breast 
cancer
4
.  
4. Race/ethnicity: 
It is a very significant intrinsic element that raises the risk of breast cancer occurrence
10
. The 
degree of breast cancer is lesser in black females i.e.113 per 100,000; American Indians/Alaska 
inhabitants i.e. 92 per 100,000; Hispanic females i.e. 90 per 100,000; and it is lowermost in 
Asian Americans/Pacific Islanders i.e. 82 per 100,000
9
.Ban et al.
20
 examined the data 
incorporated in database of SEER (Surveillance, Epidemiology, and End Results) in his study, 
and found breast cancer occurrence in Caucasian females to be approximately 127.4 in 100 000 
persons. 
5. Weight: 
Body mass index has been linked to an augmented risk of breast carcinoma chiefly in 
postmenopausal femlaes
21,22
 while a higher body mass index (BMI) is related to a diminished 
 premenopausal breast cancer risk, though the process behind this relationship is unclear. Those 
women who are more active than others are at 15-20% decreased risk
23
.To study the association 
between BMI and breast cancer, 570,000 Norwegian females (aged 30 to 69 years) were enrolled 
and studied. The follow up was taken for 6 to 18 years regarding occurrence and consequences 
of breast cancer
24
.BMI was not observed as a risk factor forpre-menopausal breast cancer but in 
case of postmenopausal females, the relative risk of occurrence of breast cancer in the highest 
versus the lowest BMI quintile was 1.1 (in females from 55 to 59 years of age) , 1.18 (in females 
from 60 to 64 yearsof age) and 1.22 (in females aged 65 to 69 years).Furthermore, a number of 
researches propose that greater BMI is linked with greater insulin and insulin-like growth factors 
levels that are related to enhanced breast cancer risk
25-27
.  This is of exceptional significance in 
peri- and postmenopausal females since body fat accumulation in such ages is generally 
abdominal, and abdominal obesity is intensely linked with hyper-insulinemia which is a breast 
cancer risk factor
28
. 
6. Increased exposure of estrogen: 
a. Benign breast disease — Women may develop abnormal breast abnormalities due to 
proliferative lesions i.e. excessive progression of the glandular breast tissue or may have 
growths in fibrous tissue, ductal amplification, or non-proliferative lesions i.e. cyst 
formations. Females with a history of proliferative breast lesions have an enhanced risk 
for breast cancer, principally if there is atypical hyperplasia
9
.  
b. Breast density— Breast density is established as a strong and an independent risk factor 
of breast cancer
29
.Women whose mammograms show less dense breast have nearly 5 
times lesser breast cancer risk. Estrogen-progestin treatment is linked with a rise in % 
mammographic density (% PMD) i.e. the proportion of the total breast area covered by 
dense tissue. Histo-pathological examination have revealed that widespread PMD is 
related to a larger number of cells and total nuclear area (inclusive of epithelial and non-
epithelial cells) and an elevated quantity of collagen and glandular structures
30
leading to 
widespread percent mammographic density. 
c. High bone density — Bone has estrogen receptors and is sensitive to levels of circulating 
estrogen. So, BMD (bone mineral density) is taken as a surrogate marker to circulating 
estrogen levels. Different studies instituted that females with a greater BMD have an 
enhanced breast cancer risk
9
.  
7. Other hormonal elements: 
a. Androgens — High testosterone levels in females are related to a greater breast cancer 
risk; some investigations proposed an enhanced risk for hormone receptor-positive 
ailment specially
9
. 
b. Insulin — High levels of insulin and growth factors related to the insulin pathway may 
affect breast cancer risk
9
.  
c. Menopausal hormonal therapy — If combined oral estrogen-progestin (specifically 
conjugated equine estrogens – CEE and medroxyprogesterone acetate – MPA)31is used 
on long term basis i.e. for 5 years or more in females from 50 to 79 years of age then it 
escalates a female's risk of breast cancer and also stroke, heart diseaseand clots in legs. 
The risk of breast carcinoma on use of only estrogen for a short time does not appear to 
be increased
9
.  
8. Endogenous Hormones: 
The presence of high levels of endogenous estrogen is a distinctive risk factor leading to 
 a greater breast carcinoma incidence
10
.Post-menopausal females who have greater levels 
of testosterone and oestrogen are 2-3 times more at risk as compared to those having 
lower levels
32
.  This was also confirmed by prospective studies that there is a substantial 
relationship amid higher concentrations of sex hormones (total estradiol, estrone 
sulfate,free estradiol, estrone, dehydroepiandrosterone, 
androstenedione,dehydroepiandrosterone sulfate and testosterone) in postmenopausal 
females and greater risk of breast cancer
33
. Also, levels of circulating estrogens and 
androgens have been noticed in large cohorts of participants to play a significant part in 
the occurrence of breast cancer in premenopausal  females
34,35
. A reduced risk of breast 
carcinomawas reported due to enhanced insulin levels in females who did not take 
hormone replacement therapy; likewise, insulin-like growth factor 1 is linked with risk of 
breast cancer positively
36
. 
 
9. Oral Contraceptive Pills: 
 
Oral contraception (OC) as breast cancer risk is controversial
10
; there is an insignificant rise in 
the risk of breast carcinomaowing to the usage of oral contraceptives
37
. The risk is greater for 
attaining breast cancer when HRT (combination of estrogens and progesterone) is used by 
females for ≥15 years38 as compared to those who take oral contraceptives39. 
Hormonereplacement therapy, whether estrogen or estrogen plus progestin, is found to be related 
to an increased risk of breast cancer
40,41
.By the use of hormonal oral contraceptives, risk of 
breast cancer was observed to be increased by 24% than in those females who have never used 
them
42
; the biggest incidence increase being seen during the use of contraception. On the 
contrary, a reanalysis of various investigations revealed almost no link between oral 
contraception and breast cancer risk
43
. The inconsistencies among analyses might be linked with 
formulation changes of oral contraceptives; besides, various formulations of oral contraceptives 
might be related to various breast cancer risks. It has been instituted that the risk of breast 
carcinoma falls considerably 10 years subsequent to discontinuation of hormonal treatment; it is 
independent of the length of their use
44
. The non-triphasic levonorgestrelpreparations were not 
related to augmenting breast cancer risk
45
.  
10. Reproductive factors: 
Reproductive factors are also considered as risk for breast carcinoma. 
a. Age at time of menarche and at menopause — in the mid 19th century, the average age of 
menarche in developed states was from 16-17 years to 12-13 years which was constantly 
linked with high breast cancer risk
46
. A woman undergoing menopause at age of 55 years 
would have 30% greater breast cancer risk than the one who gets it at age of 45 
years
47
.Hence, both younger menarche age and maturemenopausal age enhance breast 
cancer risk. This is probable in a woman's lifespan owing to the extended general 
estrogen exposure
9
. It was observed by by Brinton et al. that females having menarche 
before 12 years of age had relative risk of 1.3 in lieu of invasive breast malignancy than 
those after 15 years of age
48
. 
27
 The females not experiencing menopause up to 55 years 
of age or later, presented a relative risk = 1.22 than those who had it at less than 45 years 
of age
48
.  Based on these findings, Vogel proposed that breast malignancy risk from such 
 gynecologic variables is a function of number of ovulatory menstrual cycles that a female 
experiences through her lifespan
49
.
 
b. Pregnancy and breastfeeding — Nulliparous females are more at risk to attain breast 
cancer than those who have given birth many times; the younger a female is at her first 
full-term pregnancy, the lesser her breast cancer risk
9
. This association is mostly 
concerned with postmenopausal females with hormone dependent (ER positive) breast 
cancer
42
.It has also been established that as compared to nulliparous females, the women 
having children have 30% reduced risk; with each full-term pregnancy, the risk falls 
overall by 7%
50
. Breastfeeding has been noted to be a protective factor against attaining 
breast
9
 cancer- the lengthier the period, the more will be the safety. It is considered as an 
uncertain protective factor due to indecisive results but it is considered as a modifiable 
risk factor
51
.It was also established by the Brinton studies that breast cancer risk 
augmented for nulliparous female or if the first live birth at or after 30 years of age; 
relative risk for nulliparous female was 1.67 in comparison with one having first live 
birth at less than 20 years of age and the risk for the female was 2.23 with live birth at or 
after 30 years of age
52,53
. Moreover, not any protective outcome due to early gravidity 
was observed if it was not conceded to full term
52,53
. Cell differentiation in breast may be 
the reason during last part of a female’s first full-term gravidity followed by breast 
feeding.  
11. Personal history of breast malignancy: 
Previous history of malignancy in single breast leads to an augmented risk of cancer in the 
other
9
.There is a significantly greater risk for developing invasive breast cancer in those persons 
having a former account of invasive carcinoma, carcinoma in situ, or atypical breast hyperplasia. 
Most doctors have a preference to cope such cases with conservative therapy and close 
observation, while a small number of females at elevated risk may go for prophylactic 
mastectomy
54-58
. 
a. Family history — is an intrinsic factor that increases breast cancer risk about double, 
chiefly in first-degree affected family member i.e. mother or sister. The risk further 
surges if two or more relatives are affected and also if the cancer is diagnosed below age 
of 50 years
59
.In general, < 10 % of all breast cancers are linked with inherited genetic 
mutations in one of two genes known as BRCA1 and BRCA2
9
(breast cancer 
susceptibility 1 and 2) accomplishing the functioning of tumor suppressor genes in 
cells
10
.These two genes are established to be related to an inherited susceptibility to 
ovarian and breast cancers
60
.
 
12. Lifestyle characteristics: 
Various modifiable risk factors linked with greater risk of breast cancer include: 
a. Physical inactivity — is related to an enhanced breast cancer risk; physical exercise 
seems to be protective factor in both premenopausal and postmenopausal females though 
there is no direct confirmation
9
. More active females were reported to be at 15-20% 
reduced risk
61
.Further studies have demonstrated that regular physical activity (3-5 times 
a week) reduced 20-40% breast cancer risk, supported immunological system, improved 
health overall and also the quality of life
62
. 
 
b. Smoking — particularly in premenopausal females, both passive and active tobacco 
smoking have been related to an enhanced breast cancer risk. This risk is connected with 
early start, extended period, and/or greater pack-years of smoking
9
.An in vitro study 
revealed that cigarette smoke initiated neoplastic changes in breast epithelial cells
63
. Due 
 to partial combustion of organic materials, chemical agents causingcancer i.e. polycyclic 
aromatic hydrocarbons (PAHs) are formed. There is miscellany in structure and 
biological activity of PAHs, therefore, all PAHs cannot lead to same grade of cancer. The 
metabolites of PAH can be more toxic than the parent compounds
64
rather only a mild 
positive and substantiallink between second hand(passive) smoking and breast carcinoma 
risk was recognized
68,69
. 
13. Diet: 
a. Alcohol — Alcohol ingestion as little as 3 drinks a week has been related with a 
significant risk of breast cancer. The risk seems to rise with more alcohol ingestion and is 
additive with the usage of menopausal hormone treatment
9
.Several mechanisms have 
been suggested that might enhance breast cancer risk due to alcohol ingestion. These 
mechanisms range from stimulating the carcinogens’ metabolism such as acetaldehyde to 
declining DNA repair efficacy or decreasing consumption of protective nutrients
49
.In 
alcohol users, the level of sex hormones in the blood stream is more than in the non-
users. More than 6% breast cancers have been found to be alcohol-linked in UK
70
.Breast 
cancer risk may rise by drinking even a minor quantity of alcohol since it influences the 
metabolism of estrogen in liver
71
.  
b. Dietary habits — Studies have revealed conflicting results regarding the linkamid dietary 
patterns and risk of breast cancer
4
. There have been varying patterns of relation as risk for 
breast cancer due to use of dairy products. Cheese and milk are established to be linked 
with breast malignancy due to existence ofinsulin growth factor I and pesticides 
72
.  
c. Intake of Dietary fat — An association has been seen in some researches between greater 
ingestion of dietary fat and breast cancer, even though the effect seems to be small on the 
whole
9
. There is convincing confirmation that high fat diet leads to obesity which is 
associated with breast cancer
11
. This may be an element stimulating the neoplastic 
transformation mechanism in breast cells
73
. This association leads to an augmented risk 
of breast cancer incidence deprived of overexpression of estrogen, progesterone or HER2 
receptors, mainly observed in postmenopausal women in the period
74
. Saxe et al. also 
confirmed these observations
75
.  
d. Red meat consumption — there may be an enhanced risk of hormone-positive breast 
cancer in premenopausal females if they consume more than 5 servings of red meat per 
week
9
.  
14. Environmental factors: 
a. Miscellaneous factors — There are certain compounds that are frail estrogens, very 
lipophilic, and having capability of persisting in body for ages i.e. organochlorines like 
dioxins, polychlorinated biphenyls and organochlorine pesticides like 
dichlorodiphenyltrichloroethane (DDT).  However, their relation with breast cancer has 
not been significantly established
9
. 
CONCLUSION: 
Breast cancer has been established as a common malignancy among females globally. Major risk 
factors of breast cancer take account of age, family history, socio-economic status, BMI, age at 
menarche and menopause, use of hormonal therapy, alcohol use, smoking, etc. Positive full-term 
gravidities and lactation have found to be protective elements. In general, a healthy diet and 
lifestyle may diminish the risk of attaining this disease.The risk factors may foretell the 
probabilities of developing this disease to a certain level. Knowledge and research is required in 
different geographical zones from time to time about the susceptibility elements in the 
inhabitants in order to prevent or treat and decrease its occurrence since all the established risk 
 factors of breast cancer are not applicable in every area of the world due to miscellany of various 
elements. 
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